Martorana Annalisa, Puleo Giorgia, Miceli Giovanni Carlo, Cancilla Francesco, Licciardi Mariano, Pitarresi Giovanna, Tranchina Luigi, Marrale Maurizio, Palumbo Fabio Salvatore
Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via Archirafi 32, Palermo, Italy; Fondazione Ri.MED, c/o IRCCS ISMETT, via E. Tricomi 5, 90127, Palermo, Italy(2).
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Edificio 18, Palermo, Italy; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen, 2100, Denmark.
Int J Pharm. 2025 Jan 25;669:125108. doi: 10.1016/j.ijpharm.2024.125108. Epub 2024 Dec 19.
Despite advancements in cancer treatments, therapies frequently exhibit high cytotoxicity, and surgery remains the predominant method for treating most solid tumors, often with limited success in preventing post-surgical recurrence. Implantable biomaterials, designed to release drugs at a localised site in response to specific stimuli, represent a promising approach for enhancing tumour therapy. In this study, a redox-responsive glutathione extended polyurethane urea (PolyCEGS) was used to produce paclitaxel (PTX) and gold nanorods (AuNRs) loaded electrospun membranes for combined redox/near-infrared (NIR) light-responsive release chemotherapy and hyperthermic effect. Electrospinning conditions were optimized to fabricate AuNR-loaded scaffolds, at three different AuNRs concentrations. The obtained membranes were characterized by scanning electron microscopy (SEM) analyses and photothermal profiles were evaluated by a thermocamera, showing a temperature increase, up to 42.5 °C, when exposed to NIR light (810 nm) at 3 W/cm. The AuNRs/PTX loaded scaffolds exhibited sustained PTX release, with 15 % released over 30 days and almost 1.8 times more in a simulated reductive environment. Moreover, their excellent photothermal effects and NIR light-triggered release led to significant synergic cytotoxicity in human colon cancer (HCT-116) and human breast cancer (MCF-7) cell lines. This system potentially enables controllable locoregional PTX release at the tumour site post-surgery, preventing recurrence and enhancing cytotoxicity through combined drug and PTT effects, highlighting its potential for future anticancer treatments.
尽管癌症治疗取得了进展,但治疗方法常常具有高细胞毒性,手术仍然是治疗大多数实体瘤的主要方法,然而在预防术后复发方面往往成效有限。可植入生物材料旨在响应特定刺激在局部部位释放药物,是一种增强肿瘤治疗效果的有前景的方法。在本研究中,一种氧化还原响应型谷胱甘肽扩链聚氨酯脲(PolyCEGS)被用于制备负载紫杉醇(PTX)和金纳米棒(AuNRs)的电纺膜,以实现氧化还原/近红外(NIR)光响应联合释放化疗和热疗效果。优化了电纺条件以制备三种不同AuNRs浓度的负载AuNRs的支架。通过扫描电子显微镜(SEM)分析对所得膜进行表征,并使用热成像仪评估光热曲线,结果表明在3 W/cm的810 nm近红外光照射下温度可升高至42.5°C。负载AuNRs/PTX的支架表现出PTX的持续释放,在30天内释放了15%,在模拟还原环境中的释放量几乎多出1.8倍。此外,它们优异的光热效应和近红外光触发释放导致在人结肠癌细胞系(HCT - 116)和人乳腺癌细胞系(MCF - 7)中产生显著的协同细胞毒性。该系统有可能在手术后在肿瘤部位实现可控的局部PTX释放,通过联合药物和光热疗法效应预防复发并增强细胞毒性,突出了其在未来抗癌治疗中的潜力。